Sales Development Representative, Color

There are plenty of prominent actors in the marketplace, with 23andMe the most well known. However, Color stands out from its competitors by not working in the direct-to-consumer market, but by partnering up with employers, unions and governments to provide population-wide insights. The company’s client list is impressive, including the National Institutes of Health and the State of California, as well as Salesforce, Levis and Visa.

Thanks to a near $170 million series D funding round at the beginning of 2021, the company’s value hit “unicorn” status as it surpassed $1.5 billion. The company’s future growth will be interesting to watch, with the company announcing a new behavioural healthcare solution in October 2022 alongside the acquisition of mental health platform Mood Lifters. In 2024, Color began working with OpenAI on early detection tools for cancer. These developments are in line with Color's aim to build a wider infrastructure for a tech-based public health approach and indicate a push for a future IPO.